Gynecology
Malignant Tumor
-
Technical Advantages
-
Equipment Advantages
-
Leading Experts
-
Treatment Cases
Technical Advantages
Technical Advantages
The Department of Gynecology is skilled in treating malignant tumors using [laparoscopic/open comprehensive staging surgery for malignant tumors and cytoreductive surgery].
Equipment Advantages
Equipment Advantages
-
1
3D laparoscopy, fluorescence laparoscopy.
Leading Experts
Dr. Chen Jianguo has been honored with titles such as "Yangcheng Good Doctor", "Nanyue Good Doctor", and "Lingnan Famous Doctor"; he formerly served as Deputy Director of the Obstetrics and Gynecology Department and Director of the Second Gynecology Department/Reproductive Medicine Center at Guangdong Provincial People's Hospital.
• Youth Member, Artificial Intelligence (AI) Medicine Professional Committee, Chinese Maternal and Child Health Association;
• Member of the Gynecology Committee, Guangdong Health Association;
Clinical Cases
-
10 Experts from the Department Mobilized, All Because of "It"!
-
Patient Profile
Ms. Liu, in her 50s
-
Chief Complaints
She was treated at an external hospital due to abdominal pain and distension, dyspnea, and difficulty defecating. An external hospital tumor biopsy revealed a pathological report of: sarcoma.
-
Treatment Process
A multidisciplinary consultation determined that the patient had indications for surgical treatment, but her condition was too severe. The large mass encased vital organs such as the iliac vessels, ureters, and intestines, accompanied by cardiopulmonary and renal dysfunction. Emergency surgery would pose a life-threatening risk. Therefore, it was decided to proceed with neoadjuvant chemotherapy first, and reassess the feasibility of surgical treatment after tumor shrinkage. The patient was transferred to the Department of Urology for ureteral stent placement to relieve the renal dysfunction caused by tumor compression of the ureters. After improvement, the team led by Director Kang Shijun from the Department of Medical Oncology at our hospital intervened, administering three cycles of chemotherapy. Subsequent imaging evaluation revealed a significant reduction in tumor volume. Physical examination found the tumor to be soft, with clear boundaries and a certain degree of mobility. Another multidisciplinary consultation (involving Medical Oncology, General Surgery, Urology, Clinical Nutrition, Radiology, and Anesthesiology) was organized to formulate a precise surgical plan: it was decided that the Departments of Gynecology, Gastrointestinal Surgery, and Urology would collaborate to perform a satisfactory cytoreductive surgery for the patient.
-
Technical Highlights
Multidisciplinary combined surgery, neoadjuvant chemotherapy, cytoreductive surgery
-
Therapeutic Outcomes
The surgery lasted 4 hours, with blood loss of less than 100ml and no damage to other normal organs. The procedure was successfully completed (resection of all visible tumor tissue, residual disease less than 1cm). Within one week post-surgery, the patient's bowel and urinary functions returned to normal, and the wound healed well. Not only was the huge tumor removed, but a significant psychological burden was also lifted. The patient recovered smoothly and was discharged.
-
